Greenwich LifeSciences
GLSI
21 hedge funds and large institutions have $7.21M invested in Greenwich LifeSciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 15 closing their positions.
1.76% less ownership
Funds ownership: 7.94% → 6.18% (-1.8%)
17% less capital invested
Capital invested by funds: $8.74M → $7.21M (-$1.53M)
38% less funds holding
Funds holding: 34 → 21 (-13)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
87% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$182K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$181K |
| 3 |
HF
HRT Financial
New York
|
+$111K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$50.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$448K |
| 2 |
Morgan Stanley
New York
|
-$351K |
| 3 |
Millennium Management
New York
|
-$282K |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$199K |
| 5 |
Two Sigma Investments
New York
|
-$182K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Walleye Capital
New York
| – | -$90K | -10,656 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$11K | -1,291 | Closed |
|
28
Wells Fargo
San Francisco,
California
| – | -$37 | -4 | -15% |
|
GLSI Hedge Fund Activity: Q3 2022 in Review
21 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2022, worth a combined $7.21M — down 17% from $8.74M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of GLSI and 2 opened new positions — a net loss of 13 holders — while 9 trimmed existing stakes and 4 added.
The largest buyer was Pura Vida Investments, opening a new position worth an estimated $182K. The largest seller was Renaissance Technologies, cutting an estimated $448K.
- 21 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2022, down from 34 in Q2 2022.
- Funds reported $7.21M of Greenwich LifeSciences stock for Q3 2022, down 17% quarter-over-quarter.
- 2 funds opened new Greenwich LifeSciences positions in Q3 2022 and 15 closed out, a net change of -13 holders.
- The largest Greenwich LifeSciences buyer in Q3 2022 was Pura Vida Investments, an estimated $182K added.
- The largest Greenwich LifeSciences seller in Q3 2022 was Renaissance Technologies, an estimated $448K sold.
Based on aggregated 13F filings for Q3 2022.